| Asthmatics | Controls | p-value |
Subjects n | 72 | 30 | |
Male | 42 (58.3) | 18 (60) | ns |
Age yrs | 9.4 (6.1–14.8) | 9.2 (5.7–14.1) | ns |
Chronic rhinitis ever | 22 (30.5) | 6 (20.0) | ns |
Eczema ever | 17 (23.6) | 4 (13.3) | ns |
Sensitisation | 37 (51.4) | 5 (16.7) | <0.01 |
Dose of budesonide | | | |
µg·day−1 | 400 (200–800) | | |
µg·m−2·day−1 | 363 (127–1022) | | |
Duration of treatment months | 18 (6–84) | | |
HSDS | 0.06±1.3 | | |
HVSDS# | −0.9±2.3 | | |
FEV1 % pred | 89.9±10.1¶ | 96.9±6.1 | 0.002 |
97.3±9.2+ | | ns |